GLP-1 injections, including semaglutide and tirzepatide are given with a very small needle and are generally painless or cause minimal discomfort
Molecular biology of glycinergic neurotransmission
A., Schey, C., Kole, A., Von Gallwitz, P., Whiting, A., Foerster, D., & Zozulya-Weidenfeller, A
Semaglutide, liraglutide, tirzepatide, and related incretin therapies are now being studied across cardiovascular risk, kidney outcomes, inflammation, addiction signals, neurobiology, and eye health
A random effects model was selected to perform the meta-analyses, results were expressed as weighted mean differences for continuous outcomes and relative risks for dichotomous outcomes, both with 95% confidence intervals, and with I 2 values and P values as markers of heterogeneity